RT Journal Article
SR Electronic
T1 <sup>18</sup>F-FDG PET/CT in the Management of Osteosarcoma
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 265592
DO 10.2967/jnumed.123.265592
A1 Oh, Chiwoo
A1 Bishop, Michael W.
A1 Cho, Steve Y.
A1 Im, Hyung-Jun
A1 Shulkin, Barry L.
YR 2023
UL http://jnm.snmjournals.org/content/early/2023/05/18/jnumed.123.265592.abstract
AB Osteosarcoma is the most common type of primary malignant bone tumor. 18F-FDG PET/CT is useful for staging, detecting recurrence, monitoring response to neoadjuvant chemotherapy, and predicting prognosis. Here, we review the clinical aspects of osteosarcoma management and assess the role of 18F-FDG PET/CT, in particular with regard to pediatric and young adult patients.